securities class action

Rosen Law Firm urges $YOOV investors to join securities class action by May 20, 2026 deadline, citing fraudulent promotion and insider trading allegations.

Immutep shares plummet 82.6% after discontinuing Phase III trial for eftilagimod alfa due to futility, triggering class action investigation by Rosen Law Firm.

Disc Medicine ($IRON) shares tumbled 22% following FDA rejection of its bitopertin program. Law firm investigates potential securities violations and shareholder losses.

Class action lawsuit filed against New Era Energy & Digital ($NUAI) alleging false statements about Texas data centers and New Mexico oil wells. Investors have until June 1, 2026 to seek compensation.

Rosen Law Firm alerts $PSIX investors of May 19, 2026 deadline to join securities class action alleging false statements about data center market capacity and manufacturing costs.

Rosen Law Firm alerts $GOSS investors of June 1 deadline to join securities class action over alleged Phase 3 study discrepancies.

Rosen Law Firm files class action against $ZSPC over alleged false statements in December 2024 IPO registration. Lead plaintiff deadline set for June 22, 2026.

Stellantis investors have until June 8, 2026 to join a securities lawsuit alleging false statements about earnings growth and EV strategy.

ImmunityBio faces securities lawsuit after FDA warning letter over misleading Anktiva efficacy claims. Stock plunged 21%, erasing $2 billion in market value.

Rosen Law Firm urges $VITL investors to join class action over allegedly false statements regarding ERP delays that caused 2025 guidance miss. Deadline: May 26, 2026.

Rosen Law Firm encourages $UPST investors to join class action lawsuit over alleged false statements about Model 22 AI tool. Lead plaintiff deadline June 8, 2026.

Investors in $HTGC securities have until May 19, 2026 to join class action alleging false statements on valuations and due diligence processes.

Rosen Law Firm reminds $LU investors of approaching deadline to join securities class action over alleged false statements and control weaknesses.

Medpace faces securities lawsuit alleging false backlog statements. Investors have until June 8, 2026 to join class action claiming overstated growth expectations.

Eos Energy shareholders must file by May 5, 2026, to join securities class action alleging false production capacity and battery performance claims.

Nektar Therapeutics faces securities class action lawsuit alleging false statements about REZOLVE-AA trial. Lead plaintiff deadline set for May 5, 2026.

TruBridge ($TBRG) disclosed material accounting errors across 2023-2025, triggering restatement and 10.5% stock decline. Securities litigation initiated.

Rosen Law Firm files securities class action against Boston Scientific, alleging false statements about U.S. Electrophysiology segment sustainability. Investors have until May 4 deadline to join.

Rosen Law Firm sues Camping World Holdings for alleged false statements on inventory, demand, and finances. Investors have until May 11, 2026 to join the class action.

Rosen Law Firm sues $ALDX over allegedly false reproxalap trial claims. Investors eligible for compensation; lead plaintiff deadline May 29, 2026.